Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 498-502, February 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hecht, S. S.
Right arrow Articles by Rivenson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hecht, S. S.
Right arrow Articles by Rivenson, A.

Comparative Tumorigenicity and DNA Methylation in F344 Rats by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-Nitrosodimethylamine1

Stephen S. Hecht2, Neil Trushin, Andre Castonguay and Abraham Rivenson

Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595

The tumorigenic activities and DNA methylating abilities in F344 rats of the tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the structurally related nitrosamine N-nitrosodimethylamine (NDMA) were compared. Groups of 30 male rats were given 60 s.c. injections of 0.0055 mmol/kg of either NNK or NDMA over a 20-week period (total dose, 0.33 mmol/kg). The experiment was terminated after 104 weeks. The numbers of rats with tumors were as follows for NNK and NDMA, respectively: liver, 10 and 6; lung 13 and 0; and nasal cavity, 6 and 1. NNK was significantly more tumorigenic than was NDMA toward the lung (P < 0.01) and nasal cavity (P < 0.05). Groups of rats were treated with a single s.c. injection of 0.39 mmol/kg or 0.055 mmol/kg of NNK or NDMA and the levels of 7-methylguanine and O6-methylguanine were measured in liver, lung, and nasal mucosa 1–48 h after treatment. In liver and lung, levels of 7-methylguanine and O6-methylguanine in DNA were 3–22 times (P < 0.001) greater in NDMA treated rats than in NNK treated rats. Levels of methylation induced by NDMA and NNK in the nasal mucosa were similar. The results of this study demonstrate that NNK is a more potent tumorigen than NDMA in the F344 rat and suggest that DNA methylation alone does not account for its strong tumorigenicity in rat lung and nasal mucosa.

1 Supported by National Cancer Institute Grant CA-21393. This is Paper 88 in "A Study of Chemical Carcinogenesis."

2 To whom requests for reprints should be addressed.

Received 7/25/85. Revised 10/16/85. Accepted 10/28/85.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
L. E. Sandercock, J. N. Hahn, L. Li, H.A. Luchman, J. L. Giesbrecht, L. A. Peterson, and F. R. Jirik
Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
Carcinogenesis, April 1, 2008; 29(4): 866 - 874.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
R.D.C. Barley, S. Pollock, M.C. Shallow, E. Peters, and E.W.N. Lam
Tobacco-related-compound-induced Nitrosative Stress Injury in the Hamster Cheek Pouch
J. Dent. Res., December 1, 2004; 83(12): 903 - 908.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney
Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis
Cancer Res., August 1, 2001; 61(15): 5757 - 5763.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. C. Pulling, D. M. Klinge, and S. A. Belinsky
p16INK4a and {beta}-catenin alterations in rat liver tumors induced by NNK
Carcinogenesis, March 1, 2001; 22(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. Zhang, D. L. Weddle, P. E. Thomas, B. Zheng, A. Castonguay, H. M. Schuller, and M. S. Miller
Low Levels of Expression of Cytochromes P-450 in Normal and Cancerous Fetal Pancreatic Tissues of Hamsters Treated with NNK and/or Ethanol
Toxicol. Sci., August 1, 2000; 56(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Schrader, K. I. Hirsch-Ernst, E. Scholz, G. F. Kahl, and H. Foth
Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Primary Cultures of Rat Alveolar Type II Cells
Drug Metab. Dispos., February 1, 2000; 28(2): 180 - 185.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
L. Liu, X. Qin, and S. L. Gerson
Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell
Carcinogenesis, February 1, 1999; 20(2): 279 - 284.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. J. Mitacek, K. D. Brunnemann, D. Hoffmann, T. Limsila, M. Suttajit, N. Martin, and L. S. Caplan
Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand
Carcinogenesis, January 1, 1999; 20(1): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
T. E. Gram
Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity
Pharmacol. Rev., December 1, 1997; 49(4): 297 - 342.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. L. Code, C. L. Crespi, B. W. Penman, F. J. Gonzalez, T. K. H. Chang, and D. J. Waxman
Human Cytochrome P4502B6. Interindividual Hepatic Expression, Substrate Specificity, and Role in Procarcinogen Activation
Drug Metab. Dispos., August 1, 1997; 25(8): 985 - 993.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.